Igene Biotechnology Inc (IGNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1985 | 12-1984 | 12-1983 | |
| Sales | 522 | 157 | 44 |
| Gross Profit | 522 | 157 | 44 |
| Operating Expenses | 1,731 | 2,068 | 1,567 |
| Operating Income | -1,209 | -1,911 | -1,524 |
| Interest Expense | 77 | 3 | 226 |
| Other Income | 12 | 8 | 0 |
| Pre-tax Income | -1,274 | -1,905 | -1,749 |
| Net Income Continuous | -1,274 | -1,905 | -1,749 |
| Net Income | $-1,274 | $-1,905 | $-1,749 |
| EPS Basic Total Ops | -18.48 | -100.25 | N/A |
| EPS Basic Continuous Ops | -18.48 | -100.25 | N/A |
| EPS Diluted Total Ops | -18.48 | -100.25 | N/A |
| EPS Diluted Continuous Ops | -18.48 | -100.25 | N/A |
| EBITDA(a) | $-1,209 | $-1,911 | $-1,524 |